Correlacion de los niveles de peptido natriuretico cerebral con las complicaciones de gestantes con preeclampsia en el Hospital Teodoro Maldonado Carbo en el periodo 2018-2020.

Abstract

Introduction: Preeclampsia is defined as the pathological process in which a significant increase in the blood pressure of the pregnant woman develops, causing systemic damage that can persist throughout the pregnancy and even trigger complications in the postpartum stage. Brain natriuretic peptide monitoring has the potential to help obtain an early diagnosis and improve the treatment of cardiac dysfunction that pregnant women who develop preeclampsia may present and, at the same time, could be used as a predictive marker to assess the severity of this pathology. Methodology: It consists of a retrospective study, of descriptive analysis, for which the sample consisted of 107 patients with a diagnosis of Preeclampsia treated at the Teodoro Maldonado Carbo Specialty Hospital in Guayaquil. Results: The mean age was 24 years, blood pressure between 140/90mmHg and 159/99mmHg was reported in 68.2% of cases. 98% of the patients were reported as having severe preeclampsia. 85% of the cases had BNP levels >100 pg/ml, with no correlation found with the development of HELLP syndrome (p=0.115). Association was determined with the development of Ventricular Dysfunction and mortality (p<0.05) Conclusions: Blood pressure levels between 140/90mmHg and 150/99mmHg comprise the most prevalent. Brain natriuretic peptide levels greater than 100pg/ml correspond to those with the highest prevalence in pregnant women with preeclampsia and its quantification of brain natriuretic peptide levels is very useful in determining the prognosis of pregnant women, since they correlate with the development of complications such as Ventricular Dysfunction, in addition to being directly associated with their mortality.